Desmopressin Asetat CAS:16789-98-3

Kullanım : Desmopressin Asetat gece idrar kaçırma tedavisinde kullanılır, pıhtılaşma bozuklukları ve diyabet insipidus.

Tanım:

Desmopressin (ticari isimler: Davp, DesmoMelt, Minirin, Minirin Erimesi, Ekim, Canım) vazopressin için sentetik bir alternatiftir, idrar üretimini azaltan hormon. Burundan alınabilir, intravenöz olarak, veya oral veya dil altı tablet olarak. Doktorlar diyabet insipidus tedavisi için en sık desmopressini reçete ediyor, bedwetting, or nocturia.

Başvuru :

Doctors prescribe desmopressin frequently for treatment of nocturnal enuresis (bedwetting). It is usually prescribed in the form of oral desmopressin acetate, Davp. Patients taking DDAVP are 4.5 times more likely to sleep without disruption compared with placebo.

Desmopressin can be used to promote the release of von Willebrand factor (with subsequent increase in factor VIII survival secondary to vWF complexing) in patients with coagulation disorders such as von Willebrand disease, mild hemophilia A (factor VIII deficiency), and thrombocytopenia. It can be used with uremic induced platelet dysfunction. It is not effective in the treatment of hemophilia B (factor IX deficiency), severe hemophilia A, or von Willebrand.

Desmopressin is used in the treatment of central diabetes insipidus (DI), to replace endogenous ADH that is missing in the central nervous system type of this disorder (decreased production of ADH from the posterior pituitary). It is also used in the diagnostic workup for diabetes insipidus, in order to distinguish central from nephrogenic DI.